Your browser doesn't support javascript.
loading
Memory improvement in multiple sclerosis after an extensive cognitive rehabilitation program in groups with a multicenter double-blind randomized trial.
Brissart, Helene; Omorou, Abdou Y; Forthoffer, Natacha; Berger, Eric; Moreau, Thibault; De Seze, Jerome; Morele, Elodie; Debouverie, Marc.
Afiliação
  • Brissart H; UMR 7039, Université de Lorraine, CNRS, Vandœuvre-lès-Nancy, France.
  • Omorou AY; Department of Neurology, Nancy University Hospital, Nancy, France.
  • Forthoffer N; EA 4360 Apemac, Université Lorraine, Vandœuvre-lès-Nancy, France.
  • Berger E; Inserm CIC-1433, Épidémiologie Clinique, CHRU de Nancy, Vandoeuvre-les-Nancy, France.
  • Moreau T; Department of Neurology, Nancy University Hospital, Nancy, France.
  • De Seze J; Department of Neurology, Besançon University Hospital, Besançon, France.
  • Morele E; Department of Neurology, CHU de Dijon, Dijon, France.
  • Debouverie M; Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, INSERM 1434, Strasbourg, France.
Clin Rehabil ; 34(6): 754-763, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32475261
OBJECTIVE: The aim of this study is to determine the effectiveness of an extended cognitive rehabilitation program in group's sessions in multiple sclerosis. DESIGN: Double-blind multicenter randomized trial. PARTICIPANTS: People with multiple sclerosis of 18 to 60 years, Expanded Disability Status Scale ⩽6.0, mild to moderate cognitive impairment. INTERVENTIONS: They were randomized into cognitive rehabilitation program (ProCog-SEP) or in a placebo program. ProCog-SEP comprises 13 group's sessions over 6 months and includes psychoeducational advices and cognitive exercises. Placebo program included non-cognitive exercises. No strategy and no cognitive advice were provided. MAIN MEASURES: The primary endpoint was the percentage of verbal memory learning measured by the Selective Reminding Test. A comprehensive neuropsychological assessment is carried out before and after interventions by a neuropsychologist blinded to intervention. Effectiveness of the ProCog-SEP versus Placebo has been verified using linear regression models. RESULTS: In total, 128 participants were randomized and 110 were included in the study after planning session in groups; 101 completed this trial (77.2% females); mean age: 46.1 years (±9.6); disease duration: 11.8 years (±7.5). ProCog-SEP was more effective in increasing in learning index (9.21 (95% confidence interval (CI): 1.43, 16.99); p = 0.02) and in working memory on manipulation (0.63 (95% CI: 0.17, 1.09); p = 0.01), and updating capacities (-1.1 (95% CI: -2.13, -0.06); p = 0.04). No difference was observed for other neuropsychological outcomes. Regarding quality of life outcomes, no change was observed between the two groups. CONCLUSION: These findings suggest that ProCog-SEP could improve verbal learning abilities and working memory in people with multiple sclerosis. These improvements were observed with 13 group sessions over 6 months.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Memória Episódica / Transtornos da Memória / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Cognitivo-Comportamental / Memória Episódica / Transtornos da Memória / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article